A Study of Tetrathiomolybdate (TM) Plus Capecitabine

Clinical trial NCT06134375 · RECRUITING

Trial details

NCT number: NCT06134375
Sponsor: Dartmouth-Hitchcock Medical Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Residual Disease

Start date: 2024-11-26
Primary completion: 2031-06-26
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.